Evidence map›Paper›PMID 33732505›Full record

ArticleEpigenomes2020

The Roles of the Histone Protein Modifier EZH2 in the Uterus and Placenta.

Ana M Mesa, Cheryl S Rosenfeld, Geetu Tuteja, Theresa I Medrano, Paul S Cooke

Open access · diamondAbstract read
In one paragraph

Article in Epigenomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Uterine-specificiScience · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ana M MesaDepartment of Physiological Sciences, University of Florida, Gainesville, FL 32610-0144, USA.
Cheryl S RosenfeldBond Life Sciences Center, Department of Biomedical Sciences, Thompson Center for Autism and Neurobehavioral Disorders, Informatics Institute, and Genetics Area Program, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0002-4137-3933
Geetu TutejaGenetics, Development and Cell Biology, Iowa State University, Ames, IA 50011, USA.
Theresa I MedranoDepartment of Physiological Sciences, University of Florida, Gainesville, FL 32610-0144, USA.
Paul S CookeDepartment of Physiological Sciences, University of Florida, Gainesville, FL 32610-0144, USA.
University of Florida · USIowa State University · USUniversity of Missouri · US

Funding

Endocrine Disrupting Chemicals, Epigenetic Alterations, and Autism-Like Behaviors in the Highly Social California Mouse ModelR01ES025547 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROBERTS, R. MICHAEL · 2016 to 2020
$1.9M
Transcriptional regulatory networks govering placental development.R01HD096083 · NICHD · IOWA STATE UNIVERSITY · PI TUTEJA, GEETU · 2018 to 2022
$1.5M
Role of Membrane Estrogen Receptor 1 in Uterine Epithelial Response to EstrogenR21HD088006 · NICHD · UNIVERSITY OF FLORIDA · PI COOKE, PAUL S. · 2017 to 2018
$434k
Membrane estrogen receptor 1 mediation of epigenetic effects of estrogenR03HD087528 · NICHD · UNIVERSITY OF FLORIDA · PI COOKE, PAUL S. · 2016 to 2017
$166k
NICHD NIH HHS R01 HD096083NICHD NIH HHS R03 HD087528NICHD NIH HHS R21 HD088006NIEHS NIH HHS R01 ES025547
6 · The paper itself

Abstract

Epigenetic modifications regulate normal physiological, as well as pathological processes in various organs, including the uterus and placenta. Both organs undergo dramatic and rapid restructuring that depends upon precise orchestration of events. Epigenetic changes that alter transcription and translation of gene-sets regulate such responses. Histone modifications alter the chromatin structure, thereby affecting transcription factor access to gene promoter regions. Binding of histones to DNA is regulated by addition or removal of subunit methyl and other groups, which can inhibit or stimulate transcription. Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive complex 2 (PRC2) that catalyzes tri-methylation of histone H3 at Lys 27 (H3K27me3) and subsequently suppresses transcription of genes bound by such histones. Uterine EZH2 expression exerts a critical role in development and function of this organ with deletion of this gene resulting in uterine hyperplasia and expression of cancer-associated transcripts. Elucidating the roles of EZH2 in uterus and placenta is essential as EZH2 dysregulation is associated with several uterine and placental pathologies. Herein, we discuss EZH2 functions in uterus and placenta, emphasizing its physiological and pathological importance.

Indexed as

diseaseendometrial cancerendometriumepigeneticsstromatransgenic micetrophoblast

Identifiers

PMID33732505
PMCPMC7963394
OpenAlexW3082815351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.